U.S. markets closed

TransMedics Group, Inc. (TMDX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
22.89+3.45 (+17.75%)
At close: 4:00PM EST

22.89 0.00 (0.00%)
After hours: 4:15PM EST

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 1/9/2021
Current
9/30/20206/30/20203/31/202012/31/2019
Market Cap (intraday) 5
509.54M374.20M485.84M256.28M402.32M
Enterprise Value 3
411.35M269.22M447.55M209.74M348.07M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
17.1112.3614.467.2719.07
Price/Book (mrq)
4.403.2910.424.726.34
Enterprise Value/Revenue 3
17.0937.97131.9827.8557.47
Enterprise Value/EBITDA 6
-15.82-72.58-62.89-28.23-44.92

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-3.76%
S&P500 52-Week Change 313.47%
52 Week High 323.83
52 Week Low 310.10
50-Day Moving Average 317.47
200-Day Moving Average 316.14

Share Statistics

Avg Vol (3 month) 381.95k
Avg Vol (10 day) 398.34k
Shares Outstanding 527.16M
Float 20.48M
% Held by Insiders 111.86%
% Held by Institutions 178.32%
Shares Short (Dec 30, 2020) 4850.44k
Short Ratio (Dec 30, 2020) 49.53
Short % of Float (Dec 30, 2020) 44.54%
Short % of Shares Outstanding (Dec 30, 2020) 43.13%
Shares Short (prior month Nov 29, 2020) 4937.17k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 27, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin -131.35%
Operating Margin (ttm)-121.24%

Management Effectiveness

Return on Assets (ttm)-13.41%
Return on Equity (ttm)-36.54%

Income Statement

Revenue (ttm)24.07M
Revenue Per Share (ttm)1.04
Quarterly Revenue Growth (yoy)-1.60%
Gross Profit (ttm)13.86M
EBITDA -27.68M
Net Income Avi to Common (ttm)-31.61M
Diluted EPS (ttm)-1.36
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)132.71M
Total Cash Per Share (mrq)4.89
Total Debt (mrq)34.52M
Total Debt/Equity (mrq)31.51
Current Ratio (mrq)11.31
Book Value Per Share (mrq)4.03

Cash Flow Statement

Operating Cash Flow (ttm)-30.39M
Levered Free Cash Flow (ttm)-21.05M